Effect of amlodipine on the pharmacokinetics of tacrolimus in rats

References

• Benet LZ, Izumi T, Zhang Y, et al. (1999). Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery. J Control Release 62:25–31
   PubMed Web of Science ®Google Scholar
• Bogaards JJ, Bertrand M, Jackson P, et al. (2000). Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica 30:1131–52
   PubMed Web of Science ®Google Scholar
• Choi DH, Choi JS. (2011). Effects of amlodipine on the pharmacokinetics of repaglinide. Kor J Clin Pharm 21:215–23
   Google Scholar
• Desjardins JP, Iversen PL. (1995). Inhibition of the rat cytochrome P450 3A2by an antisense phosphorothioate oligodeoxy-nucleotide in vivo. J Pharmacol Exp Ther 275:1608–13
   PubMedGoogle Scholar
• Drobitch RK, Mclellan RA, Renton KW. (1997). Amlodipine inhibits rat microsomal cytochrome P450-mediated drug biotransformation. J Pharm Sci 86:1501–3
   PubMedGoogle Scholar
• First MR. (2004). Tacrolimus based immunosuppression. J Nephrol 17:S25–31
   PubMed Web of Science ®Google Scholar
• Hooper Dk, Carle AC, Schuchter J, Goebel J. (2011). Interaction between tacrolimus and intravenous nicardipine in the treatment of post-kidney transplant hypertension at pediatric hospitals. Pediatr Transplant 15:88–95
   PubMedGoogle Scholar
• Hutchinson IV. (1997). The mode of action of prograf (FK506)and its significance for long term graft survival. New Horiz Kidney Transplant 1:22–6
   Google Scholar
• Imaoka S, Enomoto K, Oda Y, et al. (1990). Lidocaine metabolism by human cytochrome P-450s purified from hepatic microsomes: comparison of those with rat hepatic cytochrome P-450s. J Pharmacol Exp Ther 255:1385–91
   PubMed Web of Science ®Google Scholar
• Josefsson M, Zackrisson AL, Ahlner J. (1996). Effect of grapefruit juice on the pharmacokinetics of amlodipine in healthy volunteers. Eur J Clin Pharmacol 51:189–93
   PubMed Web of Science ®Google Scholar
• Kagayama A, Tanimoto S, Fujisaki J, et al. (1993). Oral absorption of FK506 in rats. Pharm Res 10:1446–50
   PubMed Web of Science ®Google Scholar
• Katoh M, Nakajima M, Yamazaki H, Yokoi T. (2000). Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4. Pharm Res 17:1189–97
   PubMed Web of Science ®Google Scholar
• Kothari J, Nash M, Zaltzman J, Ramesh Prasad GV. (2004). Diltiazem use in tacrolimus-treated renal transplant recipients. J Clin Pharm Ther 29:425–30
   PubMedGoogle Scholar
• Kuzuya T, Kobayashi T, Moriyama N, et al. (2003). Amlodipine, but not MDR1 polymorphisms, alters the pharmacokinetics of cyclosporine A in Japanese kidney transplant recipients. Transplantation 76:865–8
   PubMed Web of Science ®Google Scholar
• Leenen FH, Coletta E, Davies RA. (2007). Prevention of renal dysfunction and hypertension by amlodipine after heart transplant. Am J Cardiol 100:531–5
   PubMedGoogle Scholar
• Leroy S, Isapof A, Fargue S, et al. (2010). Tacrolimus nephrotoxicity: beware of the association of diarrhea, drug interaction and pharmacogenetics. Pediatr Nephrol 25:965–9
   PubMed Web of Science ®Google Scholar
• Li D, Zhang GL, Lou YQ, et al. (2007). Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups. J Clin Pharm Ther 32:89–95
   PubMed Web of Science ®Google Scholar
• Miki K, Miki N, Hiroshi Y, Tsuyoshi Y. (2001). Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein mediated transport. Eur J Pharm Sci 12:505–13
   PubMedGoogle Scholar
• Saeki T, Ueda K, Tanigawara Yet al. (1993). P-glycoprotein-mediated transcellular transport of MDR-reversing agents. FEBS Lett 324:99–102
   PubMed Web of Science ®Google Scholar
• Sasaki M, Maeda A, Fujimura A. (2001). Influence of diltiazem on the pharmacokinetics of amlodipine in elderly hypertensive patients. Eur J Clin Pharmacol 57:85–6
   PubMedGoogle Scholar
• Seifeldin RA, Marcos-Alvarez A, Gordon FD, et al. (1997). Nifedipine interaction with tacrolimus in liver transplant recipients. Ann Pharmacother 31:571–5
   PubMed Web of Science ®Google Scholar
• Shiraga T, Matsuda H, Nagase K, et al. (1994). Membolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver mcirosomes. Biochem Pharmacol 47:727–35
   PubMed Web of Science ®Google Scholar
• Staatz CE, Tett SE. (2004). Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet 43:623–53
   PubMed Web of Science ®Google Scholar
• Tian R, Koyabu N, Takanaga H, et al. (2002). Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates. Pharm Res 19:802–9
   PubMed Web of Science ®Google Scholar
• Toupance O, Lavaud S, Canivet E, et al. (1994). Antihypertensive effect of amlodipine and lack of interference with cyclosporine metabolism in renal transplant recipients. Hypertension 24:297–300
   PubMedGoogle Scholar
• Tuteja S, Alloway RR, Johnson JA, Gaber AO. (2001). The effect of gut metabolism on tacrolimus bioavailability in renal transplant recipients. Transplantation 71:1303–7
   PubMed Web of Science ®Google Scholar
• Venkataramanan R, Swaminathan A, Prasad T, et al. (1995). Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet 29:404–30
   PubMed Web of Science ®Google Scholar
• Wacher VJ, Wu CY, Benet LZ. (1995). Overlapping substrate specificities and tissues distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog 13:129–34
   PubMed Web of Science ®Google Scholar
• Wang EJ, Casciano CN, Clement RP, Johnson WW. (2001). Inhibition of P-glycoprotein transport function by grapefruit juice psoralen. Pharm Res 18:432–8
   PubMed Web of Science ®Google Scholar
• Yukiya H, Hiroaki S, Masahiro S, Inui K. (1998). Effects of intestinal and hepatic metabolism on the bioavailability of tacrolimus in rats. Pharm Res 15:1609–13
   PubMedGoogle Scholar
• Zhang GM, Li L, Chen WQ, et al. (2008). Population pharmacokinetic study of tacrolimus in China renal transplant patients. Yao Xue Xue Bao 43:695–701
   PubMedGoogle Scholar